These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 9555183

  • 1. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
    Scheen AJ.
    Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183
    [Abstract] [Full Text] [Related]

  • 2. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
    Peterson WL, Ciociola AA, Sykes DL, McSorley DJ, Webb DD.
    Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
    [Abstract] [Full Text] [Related]

  • 3. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD, Wurzer H, Marcelino M, Jahnsen J, Lotay N, Roberts PM.
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [Abstract] [Full Text] [Related]

  • 4. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L, Estrada R, Trujillo M, Emami S.
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
    Gisbert JP, Gonzalez L, Calvet X.
    Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
    [Abstract] [Full Text] [Related]

  • 7. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
    Van der Wouden EJ, Thijs JC, Zwet AA, Kooy A, Kleibeuker JH.
    Aliment Pharmacol Ther; 1999 Mar; 13(3):297-302. PubMed ID: 10102961
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.
    Van Oijen AH, Verbeek AL, Jansen JB, De Boer WA.
    Aliment Pharmacol Ther; 2000 Aug; 14(8):991-9. PubMed ID: 10930892
    [Abstract] [Full Text] [Related]

  • 10. [Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group].
    Sainz R, Borda F, Domínguez E, Gisbert JP.
    Rev Esp Enferm Dig; 1999 Nov; 91(11):777-84. PubMed ID: 10601771
    [Abstract] [Full Text] [Related]

  • 11. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture.
    McColm AA, McLaren A, Klinkert G, Francis MR, Connolly PC, Grinham CJ, Campbell CJ, Selway S, Williamson R.
    Aliment Pharmacol Ther; 1996 Jun; 10(3):241-50. PubMed ID: 8791946
    [Abstract] [Full Text] [Related]

  • 12. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA, Haeck PW, Otten MH, Mulder CJ.
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [Abstract] [Full Text] [Related]

  • 13. Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.
    Ciociola AA, Webb DD, Heath A, Walsh JH.
    Aliment Pharmacol Ther; 1996 Dec; 10(6):905-12. PubMed ID: 8971287
    [Abstract] [Full Text] [Related]

  • 14. The role of antisecretory drugs in the treatment of Helicobacter pylori infection.
    Peterson WL.
    Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():21-5. PubMed ID: 9146787
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ranitidine bismuth citrate.
    Chiba N, Hunt RH, Thomson AB.
    Can J Gastroenterol; 2001 Jun; 15(6):389-98. PubMed ID: 11429668
    [Abstract] [Full Text] [Related]

  • 17. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R, Campbell CJ, Clayton NM, Clitherow JW, Grinham CJ, McColm AA, McLaren A, Trevethick MA.
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [Abstract] [Full Text] [Related]

  • 18. Ranitidine bismuth citrate therapy.
    Harris A, Misiewicz JJ.
    Aliment Pharmacol Ther; 1996 Dec; 10(6):1035. PubMed ID: 8971307
    [No Abstract] [Full Text] [Related]

  • 19. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ, O'Connell S, Schnell T, Chejfec G, Seidel J, Sonnenberg A.
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [Abstract] [Full Text] [Related]

  • 20. [Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
    Ramirez Mayans JA, Zamora Davila E, Cervantes Bustamante R, Mata Rivera N, Oyervides Garcia I, Cuevas S, Zarate Mondragón FE.
    Acta Gastroenterol Latinoam; 1996 May; 26(5):281-3. PubMed ID: 9363265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.